New Targeted Inhibitor Offers Promise for Patients with Symptomatic Obstructive HCM

September 17, 2020

Article

Current therapies focus on relief of symptoms, but there is still an unmet need to address and target the molecular defects of hypertrophic cardiomyopathy.